Capricor Therapeutics | CAPR - Operating Profit


Capricor Therapeutics reported $-29.16M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Bioline Rx USD -3M 382K Mar/2026
Capricor Therapeutics USD -29.16M 2.87M Dec/2025
Cipla INR 8.88B 2.74B Jun/2026
Cytokinetics USD -179.17M 2.05M Jun/2026
Geron USD -236K 10.55M Mar/2026
Grifols EUR 320.55M 91.01M Dec/2025
Immunic USD -23.33M 2.67M Dec/2025
J&J USD 6.47B 1B Sep/2026
Plus Therapeutics USD -7.12M 1.38M Mar/2026
Prothena USD 25.79M 53M Mar/2026
PTC Therapeutics USD 45.89M 127.51M Mar/2026
Sarepta Therapeutics USD 13.29M 345.14M Jun/2026